Goldman Sachs is backing a €260million luxury health and longevity resort in Marbella, it has been announced.
The project, called Oakmond, is due to begin construction this autumn and will transform the site of the historic Incosol hotel.
It is being developed by Ilanga Capital and has secured €145million in financing from Real Estate at Goldman Sachs Alternatives.
Building is expected to take around 36 months, with Oakmond scheduled to open in the third quarter of 2029.
The sprawling development will occupy more than 53,000m2 and will sit next to the future Four Seasons development in Marbella.
Ilanga Capital describes Oakmond as an ‘advanced and integrated longevity platform’, combining high-end hospitality with preventive medicine and long-term health monitoring.
140 rooms and 28 private residences
The resort will feature a 140-room luxury hotel and 28 private residences, alongside extensive fitness facilities and a high-end gastronomic offering.
But its developers say Oakmond is intended to be much more than another luxury Marbella resort.
At its centre will be a medical platform focused on preventive medicine, clinical wellness and longevity.
According to Ilanga Capital, patients will have access to comprehensive medical diagnostics, personalised interventions and continuous health monitoring.
A data-driven ‘clinical intelligence’ system will also be used to track patients’ health over time, with the company saying care will continue beyond a guest’s physical stay at the resort.
The developers describe the concept as the first vertically integrated ‘precision health ecosystem’ of its kind, with medicine positioned as the main product and luxury hospitality providing the environment around it.
Historic Incosol transformed
The development represents a new chapter for the former Incosol hotel, which was once one of Marbella’s best-known health and wellness destinations.
Ilanga Capital acquired the site three years ago with the intention of transforming it into a new generation of medical and luxury hospitality.
Pelayo Cortina Koplowitz, founding partner of Ilanga Capital and CEO of Oakmond, said the Goldman Sachs agreement represented a major endorsement of that vision.
‘The agreement with Goldman Sachs Alternatives represents extraordinary backing for the vision we began three years ago with the acquisition of Incosol, with the aim of creating a new category and becoming the world leader in this sector,’ he said.
He added that the financing strengthened Oakmond’s ability to develop a model combining preventive medicine, wellness and high-end care in Marbella.
Read more Andalucia news at the Spanish Eye.
